Post-Polio Syndrome Management and Outcomes

Post-Polio Syndrome (PPS) emerges decades after acute poliomyelitis, characterised by new or worsening muscle weakness, fatigue, pain and functional decline. Current management relies on a multidisciplinary blend of symptomatic relief, rehabilitative strategies and targeted interventions to preserve independence and quality of life. Rehabilitation approaches emphasise energy conservation, muscle strengthening and adaptive devices, while psychological support addresses mood disturbances and coping. Pharmacological attempts at disease modification have yielded limited success, but intravenous immunoglobulin and anti-inflammatory strategies remain under investigation. Emerging non-invasive neuromodulatory techniques offer promise in modulating pain pathways and enhancing mood. Longitudinal monitoring of strength, fatigue and respiratory function guides personalised care, and multidisciplinary follow-up has been shown to stabilise or modestly improve functional outcomes. Despite many advances, the absence of validated biomarkers and curative therapies underscores the global need for further research into underlying mechanisms, novel interventions and long-term patient-centred outcomes.

Research from Nature Portfolio

A recent study explored non-invasive neuromodulatory treatments delivered by advanced electromagnetic protocols to address multifaceted symptoms in PPS. In a cohort of middle-aged survivors, three distinct protocols targeting postural control, psycho-physical balance and cervico-brachial integration produced significant reductions in chronic pain, depressive and anxiety symptoms, alongside measurable improvements in physical and psychological quality of life. These findings highlight the potential of tailored neuromodulation as an adjunct to conventional rehabilitation, offering a feasible, well-tolerated option to enhance both motor and non-motor outcomes in PPS populations.

Post-Polio Syndrome Management and Outcomes publication trend

The graph below shows the total number of articles in post-polio syndrome management and outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Post-Polio Syndrome (PPS): A late-onset condition in polio survivors marked by new muscle weakness, fatigue and pain decades after initial infection.

Neuromodulation: Non-invasive techniques that alter neural activity to relieve pain or mood symptoms, often via electromagnetic or electrical stimulation.

Intravenous Immunoglobulin (IVIG): A blood-derived therapy containing pooled antibodies used to modulate immune responses and reduce inflammation.

Longitudinal Cohort Study: An observational research design that follows the same group of individuals over an extended period to assess changes and associated factors.

References

1. Neurobiological modulation with REAC technology: enhancing pain, depression, anxiety, stress, and quality of life in post-polio syndrome subjects. Scientific Reports (2024).
2. Changes in self-reported impairments over 10 years in people with late effects of polio and associated factors: A longitudinal cohort study. Annals of Physical and Rehabilitation Medicine (2025).
3. Post-polio Syndrome: More Than Just a Lower Motor Neuron Disease. Frontiers in Neurology (2019).
4. Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up. Journal of Neuroinflammation (2012).